Halozyme partners with Oruka for psoriasis drug development deal
Go back to Halozyme partners with Oruka for psoriasis drug development deal| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 68.55 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $68.55 | 52 Week High | $18.39 | |||
| Open | $68.55 | 52 Week Low | $6.96 | |||
| Day High | $68.55 | P/E | N/A | |||
| Day Low | $68.55 | EPS | $-0.58 | |||
| Volume | 1,004 | |||||
| (NASDAQ: ORKA) | Delayed: 72.34 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $72.34 | 52 Week High | $ | |||
| Open | $72.34 | 52 Week Low | $ | |||
| Day High | $72.34 | P/E | N/A | |||
| Day Low | $72.34 | EPS | $ | |||
| Volume | 32,184 | |||||
